The Food and Drug Administration (FDA) has issued a Complete Response Letter to Abeona Therapeutics regarding the Biologics License Application for prademagene zamikeracel for the treatment of ...

Federated analysis of autosomal recessive coding variants in 29,745 developmental disorder patients from diverse populations. Nature Genetics, 2024; DOI: 10.1038/s41588-024-01910-8 ...

2. Soro L, Bartus C, Purcell S. Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies. J Clin Aesthet Dermatol. 2015;8 (5):41-46.

(RTTNews) - Abeona Therapeutics Inc. (ABEO) Tuesday said that the U.S. Food and Drug Administration (FDA) has approved ZEVASKYN, the first cell-based gene therapy for the treatment of wounds in ...